Yazar "Artaç, H." seçeneğine göre listele
Listeleniyor 1 - 6 / 6
Sayfa Başına Sonuç
Sıralama seçenekleri
Öğe The Comparison of Alternaria and Cladosporium Spore Counts in Two City, Ankara and Konya Atmosphere at 2009(WILEY-BLACKWELL, 2010) Kızılpınar, I.; Doğan, C.; Artaç, H.; Civelek, E.; Şahiner, U.; Yavuz, S.; Reisli, I.[Abstract not Available]Öğe Di George Syndrome: Clinical Heterogeneity Can Hamper the Diagnosis(Wiley-Blackwell, 2010) Göktürk, B.; Artaç, H.; Keleş, S.; Yıldırım, S.; Kara, R.; Kıraç, M.; Reisli, I.[Abstract not Available]Öğe The Reliability and Validity of Turkish Version of Childhood Asthma Control Test(SPRINGER, 2012) Şekerel, B. E.; Soyer, O. U.; Keskin, O.; Uzuner, N.; Yazıcıoğlu, M.; Kılıç, M.; Artaç, H.; Özmen, S.; Can, D.; Zeyrek, D.; Çokuğraş, H.; Canıtez, Y.; Aydoğan, M.; Kuyucu, S.; İnal, A.; Gürkan, F.; Orhan, F.; Yılmaz, O.; Boz, A. B.; Tahan, F.; Cevit, O.Introduction The reliability and validity of Turkish version of Childhood Asthma Control Test (C-ACT). Purpose The management of asthma is an important as well as difficult issue of physician's daily practice particularly in busy clinical settings. C-ACT was created to identify asthma control levels in children aged 4-11 years. Our aim was to evaluate the reliability, validity and responsiveness of C-ACT in a Turkish sample of children with asthma. Method In this multicenter study, 368 children were enrolled. C-ACT was completed every month by parents and patients who were evaluated in 3 visits within 2 month intervals. At each visit, physicians interpret the control level and decided for the treatment step as established in GINA guidelines. Results The internal consistency reliability of the Turkish version of C-ACT (C-ACT1 to C-ACT5) was found to be 0.82, 0.83, 0.82, 0.82 and 0.80, respectively (reliability statistics, Cronbach's alpha). Test-retest reliability was 0.71. There was significant correlation between C-ACT and physician's assessment of asthma control at visit 1 (r = 0.65, P < 0.001). Conclusions Turkish version of C-ACT is an accurate and reliable tool to evaluate asthma control in children aged 4-11 years. Its widespread use may facilitate appropriate assessment of asthma control and may lead to decrease the number of uncontrolled patients.Öğe Swine Influenza a (H1N1) Infections in Patients with Primary Immunodeficiency(WILEY-BLACKWELL, 2010) Kıraç, M.; Göktürk, B.; Keleş, S.; Artaç, H.; Reisli, I.[Abstract not Available]Öğe Thrombocyte Volume and Count in Digeorge Syndrome(SPRINGER/PLENUM PUBLISHERS, 2012) Göktürk, B.; Reisli, I.; Kıraç, M.; Keleş, S.; Artaç, H.; Yıldırım, S.[Abstract not Available]Öğe Type III Bare Lymphocyte Syndrome Associated with a Novel RFXAP Mutation: A Case Report(WILEY-BLACKWELL, 2012) Göktürk, B.; Artaç, H.; van Eggermond, M. J.; van den Elsen, P.; Reisli, İ.Type III bare lymphocyte syndrome (BLS) is a severe combined immunodeficiency disease caused by the absence of MHC Class II expression associated with low expression of class I molecules. Here, we report a case with type III BLS who lacked RFXAP (Regulatory factor X-associated protein) expression as a result from a novel mutation introducing a premature stopcodon in DE-region at amino acid 73.